A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis

Background  rVIII-SingleChain is a recombinant factor VIII (FVIII) with increased binding affinity to von Willebrand factor compared with other FVIII products. rVIII-SingleChain is indicated for the treatment and prevention of bleeding episodes in patients with hemophilia A. Objectives  To collect r...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillet, Benoit, Hassoun, Abel, Wibaut, Bénédicte, Harroche, Annie, Biron-Andréani, Christine, Repesse, Yohan, d'Oiron, Roseline, Tardy, Brigitte, Pan Petesch, Brigitte, Chamouni, Pierre, Gay, Valérie, Fouassier, Marc, Pouplard, Claire, Martin, Cédric, Catovic, Hasan, Delavenne, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113037/
https://www.ncbi.nlm.nih.gov/pubmed/36758611
http://dx.doi.org/10.1055/s-0043-1761449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113037/
https://www.ncbi.nlm.nih.gov/pubmed/36758611
http://dx.doi.org/10.1055/s-0043-1761449

Ejemplares similares